What have we learned from the biological therapies in ulcerative colitis?
Peña
A S
AS
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000517:prevention & control*; D005544:Forecasting; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use; D011994:Recombinant Proteins
D000893:Anti-Inflammatory Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins